
| (Commission File Number) | (IRS Employer Identification No.) | |||||||
| Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) | |||||
| Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) | |||||
| Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) | |||||
| Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) | |||||
| Title of each class | Trading Symbol(s) | Name of each exchange on which registered | ||||||
| Item 2.02. | Results of Operations and Financial Condition. | ||||
| Item 7.01. | Regulation FD Disclosure. | ||||
| Item 9.01. | Financial Statements and Exhibits. | ||||
| Exhibit Number | Exhibit Description | Filed Herewith | ||||||
| 99.1 | X | |||||||
| 99.2 | X | |||||||
| 99.3 | X | |||||||
| 104 | Cover page interactive data file - The cover page from this Current Report on Form 8-K is formatted as Inline XBRL | X | ||||||
| TRUEBLUE, INC. | ||||||||||||||
| (Registrant) | ||||||||||||||
| Date: | May 5, 2025 | By: | /s/ Carl R. Schweihs | |||||||||||
Carl R. Schweihs | ||||||||||||||
Chief Financial Officer and Executive Vice President | ||||||||||||||
13 weeks ended | |||||||||||
| (in thousands, except per share data) | Mar 30, 2025 | Mar 31, 2024 | |||||||||
| Revenue from services | $ | 370,254 | $ | 402,853 | |||||||
| Cost of services | 283,912 | 303,467 | |||||||||
| Gross profit | 86,342 | 99,386 | |||||||||
| Selling, general and administrative expense | 94,621 | 106,937 | |||||||||
| Depreciation and amortization | 5,844 | 7,958 | |||||||||
| Loss from operations | (14,123) | (15,509) | |||||||||
Interest and other income (expense), net | 193 | 1,599 | |||||||||
Loss before tax expense (benefit) | (13,930) | (13,910) | |||||||||
| Income tax expense (benefit) | 418 | (12,212) | |||||||||
| Net loss | $ | (14,348) | $ | (1,698) | |||||||
| Net loss per common share: | |||||||||||
| Basic | $ | (0.48) | $ | (0.05) | |||||||
| Diluted | $ | (0.48) | $ | (0.05) | |||||||
| Weighted average shares outstanding: | |||||||||||
| Basic | 29,698 | 31,102 | |||||||||
| Diluted | 29,698 | 31,102 | |||||||||
| (in thousands) | Mar 30, 2025 | Dec 29, 2024 | |||||||||
| ASSETS | |||||||||||
| Cash and cash equivalents | $ | 23,059 | $ | 22,536 | |||||||
| Accounts receivable, net | 219,056 | 214,704 | |||||||||
| Other current assets | 38,932 | 39,853 | |||||||||
| Total current assets | 281,047 | 277,093 | |||||||||
| Property and equipment, net | 87,851 | 89,602 | |||||||||
Restricted cash, cash equivalents and investments | 170,208 | 179,916 | |||||||||
| Goodwill and intangible assets, net | 62,673 | 30,406 | |||||||||
| Other assets, net | 90,692 | 98,359 | |||||||||
| Total assets | $ | 692,471 | $ | 675,376 | |||||||
| LIABILITIES AND SHAREHOLDERS’ EQUITY | |||||||||||
| Accounts payable and other accrued expenses | $ | 38,026 | $ | 45,599 | |||||||
| Accrued wages and benefits | 66,339 | 61,380 | |||||||||
| Current portion of workers’ compensation claims reserve | 31,397 | 34,729 | |||||||||
| Other current liabilities | 20,562 | 18,417 | |||||||||
| Total current liabilities | 156,324 | 160,125 | |||||||||
| Workers’ compensation claims reserve, less current portion | 91,531 | 105,063 | |||||||||
| Long-term debt, less current portion | 57,800 | 7,600 | |||||||||
| Other long-term liabilities | 84,599 | 87,229 | |||||||||
| Total liabilities | 390,254 | 360,017 | |||||||||
| Shareholders’ equity | 302,217 | 315,359 | |||||||||
| Total liabilities and shareholders’ equity | $ | 692,471 | $ | 675,376 | |||||||
13 weeks ended | |||||||||||
| (in thousands) | Mar 30, 2025 | Mar 31, 2024 | |||||||||
| Cash flows from operating activities: | |||||||||||
| Net loss | $ | (14,348) | $ | (1,698) | |||||||
| Adjustments to reconcile net loss to net cash (used in) provided by operating activities: | |||||||||||
Depreciation and amortization (inclusive of depreciation included in cost of services) | 6,810 | 7,958 | |||||||||
| Provision for credit losses | 250 | 370 | |||||||||
| Stock-based compensation | 2,060 | 2,102 | |||||||||
| Deferred income taxes | — | (12,206) | |||||||||
| Non-cash lease expense | 2,753 | 3,036 | |||||||||
| Other operating activities | 1,486 | (2,980) | |||||||||
| Changes in operating assets and liabilities: | |||||||||||
| Accounts receivable | 9,133 | 8,292 | |||||||||
| Income taxes receivable and payable | 373 | 975 | |||||||||
| Other assets | 7,150 | 1,571 | |||||||||
| Accounts payable and other accrued expenses | (9,580) | (11,515) | |||||||||
| Accrued wages and benefits | (5,418) | 480 | |||||||||
| Workers’ compensation claims reserve | (16,865) | (8,669) | |||||||||
| Operating lease liabilities | (3,035) | (3,204) | |||||||||
| Other liabilities | (2,884) | 1,249 | |||||||||
Net cash used in operating activities | (22,115) | (14,239) | |||||||||
| Cash flows from investing activities: | |||||||||||
| Capital expenditures | (4,680) | (7,375) | |||||||||
| Acquisition of business, net of cash acquired | (30,044) | — | |||||||||
| Proceeds from business divestiture, net | — | 2,928 | |||||||||
| Purchases of restricted held-to-maturity investments | — | (10,180) | |||||||||
| Maturities of restricted held-to-maturity investments | 10,756 | 15,546 | |||||||||
Net cash (used in) provided by investing activities | (23,968) | 919 | |||||||||
| Cash flows from financing activities: | |||||||||||
| Purchases and retirement of common stock | — | (10,067) | |||||||||
| Net proceeds from employee stock purchase plans | 70 | 220 | |||||||||
| Common stock repurchases for taxes upon vesting of restricted stock | (895) | (2,012) | |||||||||
| Net change in revolving credit facility | 50,200 | — | |||||||||
| Other | (6) | (1,803) | |||||||||
Net cash provided by (used in) financing activities | 49,369 | (13,662) | |||||||||
| Effect of exchange rate changes on cash, cash equivalents and restricted cash and cash equivalents | (230) | (604) | |||||||||
| Net change in cash, cash equivalents, and restricted cash and cash equivalents | 3,056 | (27,586) | |||||||||
| Cash, cash equivalents and restricted cash and cash equivalents, beginning of period | 61,100 | 99,306 | |||||||||
| Cash, cash equivalents and restricted cash and cash equivalents, end of period | $ | 64,156 | $ | 71,720 | |||||||
13 weeks ended | |||||||||||
| (in thousands) | Mar 30, 2025 | Mar 31, 2024 | |||||||||
| Revenue from services: | |||||||||||
| PeopleReady | $ | 189,305 | $ | 222,661 | |||||||
| PeopleManagement | 135,532 | 133,860 | |||||||||
PeopleSolutions (1) | 45,417 | 46,332 | |||||||||
| Total company | $ | 370,254 | $ | 402,853 | |||||||
Segment profit (loss)(2): | |||||||||||
| PeopleReady | $ | (2,974) | $ | (5,058) | |||||||
| PeopleManagement | 2,894 | 2,751 | |||||||||
PeopleSolutions | 1,952 | 4,879 | |||||||||
| Total segment profit | 1,872 | 2,572 | |||||||||
| Corporate unallocated expense | (5,794) | (6,052) | |||||||||
Total company Adjusted EBITDA (3) | (3,922) | (3,480) | |||||||||
Third-party processing fees for hiring tax credits (4) | (90) | (90) | |||||||||
Amortization of software as a service assets (5) | (1,093) | (1,343) | |||||||||
| Acquisition/integration costs | (710) | — | |||||||||
PeopleReady technology upgrade costs (6) | — | (385) | |||||||||
| COVID-19 government subsidies, net | — | (44) | |||||||||
Other adjustments, net (7) | (1,498) | (2,209) | |||||||||
EBITDA (2) | (7,313) | (7,551) | |||||||||
Depreciation and amortization (8) | (6,810) | (7,958) | |||||||||
Interest and other income (expense), net | 193 | 1,599 | |||||||||
Loss before tax (expense) benefit | (13,930) | (13,910) | |||||||||
Income tax (expense) benefit | (418) | 12,212 | |||||||||
| Net loss | $ | (14,348) | $ | (1,698) | |||||||
| Non-GAAP measure | Definition | Purpose of adjusted measures | ||||||||||||
Adjusted net income (loss) and Adjusted net income (loss) per diluted share | Net loss and net loss per diluted share, excluding: –gain on divestiture, –amortization of intangibles, –acquisition/integration costs, –PeopleReady technology upgrade costs, –COVID-19 government subsidies, net, –other adjustments, net, and –tax effect of the adjustments and deferred tax asset valuation allowance. | –Enhances comparability on a consistent basis and provides investors with useful insight into the underlying trends of the business. –Used by management to assess performance and effectiveness of our business strategies. –Provides a measure, among others, used in the determination of incentive compensation for management. | ||||||||||||
| EBITDA and Adjusted EBITDA | EBITDA excludes from net loss: –income tax expense (benefit), –interest and other (income) expense, net, and –depreciation and amortization. Adjusted EBITDA further excludes: –third-party processing fees for hiring tax credits, –amortization of software as a service assets, –acquisition/integration costs, –PeopleReady technology upgrade costs, –COVID-19 government subsidies, net, and –other adjustments, net. | –Enhances comparability on a consistent basis and provides investors with useful insight into the underlying trends of the business. –Used by management to assess performance and effectiveness of our business strategies. –Provides a measure, among others, used in the determination of incentive compensation for management. | ||||||||||||
| Adjusted SG&A expense | Selling, general and administrative expense excluding: –third-party processing fees for hiring tax credits, –amortization of software as a service assets, –acquisition/integration costs, –PeopleReady technology upgrade costs, –COVID-19 government subsidies, net, and –other adjustments, net. | –Enhances comparability on a consistent basis and provides investors with useful insight into the underlying trends of the business. | ||||||||||||
13 weeks ended | |||||||||||
| (in thousands, except for per share data) | Mar 30, 2025 | Mar 31, 2024 | |||||||||
| Net loss | $ | (14,348) | $ | (1,698) | |||||||
Gain on divestiture | — | (745) | |||||||||
| Amortization of intangible assets | 401 | 1,521 | |||||||||
| Acquisition/integration costs | 710 | — | |||||||||
PeopleReady technology upgrade costs (1) | — | 385 | |||||||||
| COVID-19 government subsidies, net | — | 44 | |||||||||
Other adjustments, net (2) | 1,498 | 2,209 | |||||||||
Tax effect of adjustments and deferred tax asset valuation allowance (3) | — | (888) | |||||||||
Adjusted net income (loss) | $ | (11,739) | $ | 828 | |||||||
Adjusted net income (loss) per diluted share | $ | (0.40) | $ | 0.03 | |||||||
| Diluted weighted average shares outstanding | 29,698 | 31,380 | |||||||||
| Margin / % of revenue: | |||||||||||
Net loss | (3.9)% | (0.4)% | |||||||||
Adjusted net income (loss) | (3.2)% | 0.2% | |||||||||
13 weeks ended | |||||||||||
| (in thousands) | Mar 30, 2025 | Mar 31, 2024 | |||||||||
| Net loss | $ | (14,348) | $ | (1,698) | |||||||
Income tax expense (benefit) | 418 | (12,212) | |||||||||
Interest and other (income) expense, net | (193) | (1,599) | |||||||||
Depreciation and amortization (4) | 6,810 | 7,958 | |||||||||
| EBITDA | (7,313) | (7,551) | |||||||||
Third-party processing fees for hiring tax credits (5) | 90 | 90 | |||||||||
Amortization of software as a service assets (6) | 1,093 | 1,343 | |||||||||
| Acquisition/integration costs | 710 | — | |||||||||
PeopleReady technology upgrade costs (1) | — | 385 | |||||||||
| COVID-19 government subsidies, net | — | 44 | |||||||||
Other adjustments, net (2) | 1,498 | 2,209 | |||||||||
| Adjusted EBITDA | $ | (3,922) | $ | (3,480) | |||||||
| Margin / % of revenue: | |||||||||||
Net loss | (3.9)% | (0.4)% | |||||||||
| Adjusted EBITDA | (1.1)% | (0.9)% | |||||||||
13 weeks ended | |||||||||||
| (in thousands) | Mar 30, 2025 | Mar 31, 2024 | |||||||||
| Selling, general and administrative expense | $ | 94,621 | $ | 106,937 | |||||||
Third-party processing fees for hiring tax credits (5) | (90) | (90) | |||||||||
Amortization of software as a service assets (6) | (1,093) | (1,343) | |||||||||
| Acquisition/integration costs | (710) | — | |||||||||
PeopleReady technology upgrade costs (1) | — | (385) | |||||||||
| COVID-19 government subsidies, net | — | (44) | |||||||||
Other adjustments, net (2) | (1,395) | (2,113) | |||||||||
| Adjusted SG&A expense | $ | 91,333 | $ | 102,962 | |||||||
| % of revenue: | |||||||||||
| Selling, general and administrative expense | 25.6% | 26.5% | |||||||||
| Adjusted SG&A expense | 24.7% | 25.6% | |||||||||